CoChat

CONSORT extension for reporting N-of-1 trials (CENT) 2015: explanation and elaboration

Open access
Shamseer, Larissa, Sampson, Margaret, Bukutu, Cecilia, Schmid, Christopher H., Nikles, Jane, Tate, Robyn, Johnston, Bradley C., Zucker, Deborah, Shadish, William R., Kravitz, Richard, Guyatt, Gordon, Altman, Douglas G., Moher, David, Vohra, Sunita, Altman, Douglas G., Bukutu, Cecilia, Clark, Jocalyn, Cogo, Elise, Gabler, Nicole B., Guyatt, Gordon, Kravitz, Richard, Janosky, Janine, Johnston, Bradley C., Li, Bob, Mahon, Jeff, Marles, Robin, Moher, David, Nikles, Jane, Sampson, Margaret, Schmid, Christopher H., Shadish, William R., Shamseer, Larissa, Tate, Robyn, Vohra, Sunita, Zucker, Deborah · 2016 · Journal of Clinical Epidemiology
Cited by 143

The DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.

Abstract

N-of-1 trials are a useful tool for clinicians who want to determine the effectiveness of a treatment in a particular individual. The reporting of N-of-1 trials has been variable and incomplete, hindering their usefulness in clinical decision making and by future researchers. This document presents the CONSORT (Consolidated Standards of Reporting Trials) extension for N-of-1 trials (CENT 2015). CENT 2015 extends the CONSORT 2010 guidance to facilitate the preparation and appraisal of reports of an individual N-of-1 trial or a series of prospectively planned, multiple, crossover N-of-1 trials. CENT 2015 elaborates on 14 items of the CONSORT 2010 checklist, totalling 25 checklist items (44 sub-items), and recommends diagrams to help authors document the progress of one participant through a trial or more than one participant through a trial or series of trials, as applicable. Examples of good reporting and evidence based rationale for CENT 2015 checklist items are provided.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.jclinepi.2015.05.018

Cites

25 of 25 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 82

  1. Gitterman, 2008, That sinking feeling, again? the state of national institutes of health pediatric research funding, fiscal year 1992-2010, Pediatr Res, 64, 462, 10.1203/PDR.0b013e31818912fd · DOI
  2. Gagne, 2014, Innovative research methods for studying treatments for rare diseases: methodological review, BMJ, 349, g6802, 10.1136/bmj.g6802 · DOI · Paper page
  3. Fortin, 2006, Randomized controlled trials: do they have external validity for patients with multiple comorbidities?, Ann Fam Med, 4, 104, 10.1370/afm.516 · DOI · Paper page
  4. Zarin, 2005, Challenges to evidence-based medicine, Soc Psychiatry Psychiatr Epidemiol, 40, 27, 10.1007/s00127-005-0838-9 · DOI
  5. Schwartz, 2009, Explanatory and pragmatic attitudes in therapeutical trials, J Clin Epidemiol, 62, 499, 10.1016/j.jclinepi.2009.01.012 · DOI · Paper page
  6. Van den Akker, 1998, Multimorbidity in general practice: prevalence, incidence, and determinants of co-occurring chronic and recurrent diseases, J Clin Epidemiol, 51, 367, 10.1016/S0895-4356(97)00306-5 · DOI · Paper page
  7. Zucker, 1997, Combining single patient (N-of-1) trials to estimate population treatment effects and to evaluate individual patient responses to treatment, J Clin Epidemiol, 50, 401, 10.1016/S0895-4356(96)00429-5 · DOI · Paper page
  8. OCEBM Levels of Evidence Working Group. The Oxford levels of evidence 2. Oxford Centre for Evidence-Based Medicine, 2011. Available at www.cebm.net/index.aspx?o55653. Accessed December 14, 2014.
  9. Hersen, 1990, Chapter 9: Single-case experimental designs, 175
  10. Tate, 2012, Developing reporting guidelines for single-case experimental designs: the SCRIBE project, Brain Impairment, 13, 135
  11. Turner L, Moher D, Shamseer L, Weeks L, Peters J, Plint A, et al. The influence of CONSORT on the quality of RCTs: an updated review. 9th Annual Cochrane Canada Symposium, 2011.
  12. Vohra, 2015, CONSORT extension for reporting N-of-1 trials (CENT) 2015 Statement, BMJ, 350, h1738, 10.1136/bmj.h1738 · DOI · Paper page
  13. Moher, 2010, Guidance for developers of health research reporting guidelines, Plos Med, 7, e1000217, 10.1371/journal.pmed.1000217 · DOI · Paper page
  14. Price, 2002, An N-of-1 randomized controlled trial (‘N-of-1 trial’) of donepezil in the treatment of non-progressive amnestic syndrome, Age Ageing, 31, 307, 10.1093/ageing/31.4.307 · DOI
  15. Wegman, 2005, Efficacy of temazepam in frequent users: a series of N-of-1 trials, Fam Pract, 22, 152, 10.1093/fampra/cmh726 · DOI
  16. Träder, 2007, Mutterkraut als prophylaktische phytotherapie bei migräne: N-of-1-studie zum individuellen wirksamkeitsnachweis [feverfew as preventive therapy for migraine: N-of-1-trial for verification of individual efficacy], ZFA, 83, 238, 10.1055/s-2007-977710 · doi:10.1055/s-2007-977710
  17. Nonoyama, 2007, Effect of oxygen on health quality of life in COPD patients with transient exertional hypoxemia, Am J Respir Crit Care Med, 176, 343, 10.1164/rccm.200702-308OC · DOI
  18. Pereira, 2005, Are brand-name and generic warfarin interchangeable? multiple n-of-1 randomized, crossover trials, Ann Pharmacother, 39, 1188, 10.1345/aph.1G003 · DOI
  19. Kamien, 1998, The use of an N-of-1 randomised clinical trial in resolving therapeutic doubt. the case of a patient with an ‘attention disorder’, Aust Fam Physician, 27, S103
  20. Sung, 2007, Serial controlled N-of-1 trials of topical vitamin E as prophylaxis for chemotherapy-induced oral mucositis in paediatric patients, Eur J Cancer, 43, 1269, 10.1016/j.ejca.2007.02.001 · DOI
  21. Louly, 2009, N-of-1 double-blind, randomized controlled trial of tramadol to treat chronic cough, Clin Ther, 31, 1007, 10.1016/j.clinthera.2009.05.015 · doi:10.1016/j.clinthera.2009.05.015
  22. Wegman, 2003, de HM, Deville WL, Fo CT, de Vries TP. Switching from NSAIDs to paracetamol: a series of n of 1 trials for individual patients with osteoarthritis, Ann Rheum Dis, 62, 1156, 10.1136/ard.2002.002865 · DOI
  23. Smith, 2004, Eformoterol n-of-1 trials in chronic obstructive pulmonary disease poorly reversible to salbutamol, Chron Respir Dis, 1, 63, 10.1191/1479972304cd028oa · DOI
  24. Johannessen, 1992, Cimetidine on-demand in dyspepsia. experience with randomized controlled single-subject trials, Scand J Gastroenterol, 27, 189, 10.3109/00365529208999947 · DOI
  25. Fedele, 1993, Effects of medication on parotid salivary flow rates in an individual with dementia of the alzheimer type, Spec Care Dentist, 13, 215, 10.1111/j.1754-4505.1993.tb01499.x · DOI
  26. Coxeter, 2003, Valerian does not appear to reduce symptoms for patients with chronic insomnia in general practice using a series of randomised n-of-1 trials, Complement Ther Med, 11, 215, 10.1016/S0965-2299(03)00122-5 · DOI
  27. Nathan, 2006, A pilot study of ondansetron plus metopimazine vs. ondansetron monotherapy in children receiving highly emetogenic chemotherapy: a bayesian randomized serial N-of-1 trials design, Support Care Cancer, 14, 268
  28. Irwig, 1995, Ethics of n-of-1 trials, Lancet, 345, 469, 10.1016/S0140-6736(95)90578-2 · DOI
  29. Mahon, 1995, Ethics of n-of-1 trials, Lancet, 345, 989, 10.1016/S0140-6736(95)90738-6 · DOI
  30. Zucker, 2010, Individual (N-of-1) trials can be combined to give population comparative treatment effect estimates: methodologic considerations, J Clin Epidemiol, 63, 1312, 10.1016/j.jclinepi.2010.04.020 · DOI · Paper page
  31. Punja S, Eslick I, Duan N, Vohra S, the DEcIDE Methods Center N-of-1 Guidance Panel. Chapter 2: An ethical framework for N-of-1 trials: clinical care, quality improvement, or human subjects research? In: Kravitz RL, Duan N, and the DEcIDE Methods Center N-of-1 Guidance Panel, eds. Design and implementation of N-of-1 trials: a user’s guide. AHRQ Publication No 13(14)-EHC122-EF. Agency for Healthcare Research and Quality, 2014:13–22.
  32. Guyatt, 1986, Determining optimal therapy–randomized trials in individual patients, N Engl J Med, 314, 889, 10.1056/NEJM198604033141406 · DOI · Paper page
  33. Gagnier, 2006, Recommendations for reporting randomized controlled trials of herbal interventions: explanation and elaboration, J Clin Epidemiol, 59, 1134, 10.1016/j.jclinepi.2005.12.020 · DOI · Paper page
  34. MacPherson, 2010, Revised STandards for reporting interventions in clinical trials of acupuncture (STRICTA): Extending the CONSORT statement, Acupunct Med, 28, 83, 10.1136/aim.2009.001370 · DOI · Paper page
  35. McLeod, 1986, Single-patient randomised clinical trial. use in determining optimum treatment for patient with inflammation of Kock continent ileostomy reservoir, Lancet, 1, 726, 10.1016/S0140-6736(86)91112-8 · DOI
  36. Guyatt, 2004, Patients at the center: in our practice, and in our use of language, ACP J Club, 140, A11, 10.7326/ACPJC-2004-140-1-A11 · DOI · Paper page
  37. Gandhi, 2008, Patient-important outcomes in registered diabetes trials, JAMA, 299, 2543, 10.1001/jama.299.21.2543 · DOI · Paper page
  38. Paterson, 1996, Measuring outcomes in primary care: a patient generated measure, MYMOP, compared with the SF-36 health survey, BMJ, 312, 1016, 10.1136/bmj.312.7037.1016 · DOI · Paper page
  39. Paterson, 2005, A pilot study of therapeutic massage for people with parkinson’s disease: the added value of user involvement, Complement Ther Clin Pract, 11, 161, 10.1016/j.ctcp.2004.12.008 · DOI
  40. Dziegielewski, 2000, Eye movement desensitization and reprocessing (EMDR) as a time-limited treatment intervention for body image disturbance and self-esteem: a single subject case study design, J Psychother Independent Pract, 1, 1, 10.1300/J288v01n03_01 · DOI
  41. Johnston, 2010, Measurement issues in trials of pediatric acute diarrheal diseases: a systematic review, Pediatrics, 126, e222, 10.1542/peds.2009-3667 · DOI · Paper page
  42. Sinha, 2012, Standard 5: selection, measurement, and reporting of outcomes in clinical trials in children, Pediatrics, 129, S146, 10.1542/peds.2012-0055H · DOI
  43. Miyar, 2013, Content and quality of 10,000 controlled trials in schizophrenia over 60 years, Schizophr Bull, 39, 226, 10.1093/schbul/sbr140 · DOI · Paper page
  44. Zwaigenbaum, 2006, “N of 1” trials of methylphenidate in two children with Williams syndrome and attention deficit hyperactivity disorder, J Dev Phys Disabil, 18, 45, 10.1007/s10882-006-9005-9 · DOI
  45. Nikles, 2011, Aggregating single patient (n-of-1) trials in populations where recruitment and retention was difficult: the case of palliative care, J Clin Epidemiol, 64, 471, 10.1016/j.jclinepi.2010.05.009 · DOI
  46. Cepeda, 2008, An N-of-1 trial as an aid to decision-making prior to implanting a permanent spinal cord stimulator, Pain Med, 9, 235, 10.1111/j.1526-4637.2007.00329.x · DOI
  47. Montori, 2005, Randomized trials stopped early for benefit: a systematic review, JAMA, 294, 2203, 10.1001/jama.294.17.2203 · DOI · Paper page
  48. Bassler, 2010, Stopping randomized trials early for benefit and estimation of treatment effects, JAMA, 303, 1180, 10.1001/jama.2010.310 · DOI · Paper page
  49. Nikles, 2005, Do individualized medication effectiveness tests (n-of-1 trials) change clinical decisions about which drugs to use for osteoarthritis and chronic pain?, Am J Ther, 12, 92, 10.1097/00045391-200501000-00012 · DOI
  50. Morrow, 2006, Comparing fixed- and randomized-interval spaced retrieval in anomia treatment, J Commun Disord, 39, 2, 10.1016/j.jcomdis.2005.05.001 · DOI
  51. Schmid CH, Duan N, the DEcIDE Methods Center N-of-1 Guidance Panel. Chapter 4: Statistical design and analytic considerations for N-of-1 trials. In: Kravitz RL, Duan N, DEcIDE Methods Center N-of-1 Guidance Panel, editors. Design and implementation of N-of-1 trials: a user’s guide. AHRQ Publication No 13(14)-EHC122-EF ed. Agency for Healthcare Research and Quality, 2014:33–53.
  52. Woodfield, 2005, N-of-1 trials of quinine efficacy in skeletal muscle cramps of the leg, Br J Gen Pract, 55, 181
  53. Price, 2002, N-of-1 randomized controlled trials (‘N-of-1 trials’): singularly useful in geriatric medicine, Age Ageing, 31, 227, 10.1093/ageing/31.4.227 · doi:10.1093/ageing/31.4.227
  54. Arroll, 1989, Single case randomised trial of tryptophan vs placebo, NZ Fam Physician, 16, 14
  55. International Committee of Medical Journal Editors, 1997, Uniform requirements for manuscripts submitted to biomedical journals, Ann Intern Med, 126, 36, 10.7326/0003-4819-126-1-199701010-00006 · DOI · Paper page
  56. Gage, 2013, Analysis of effect for single-case design research, J Appl Sport Psychol, 25, 46, 10.1080/10413200.2012.660673 · DOI · Paper page
  57. Horner, 2012, Considerations for the systematic analysis and use of single-case research, Educ Treat Child, 35, 269, 10.1353/etc.2012.0011 · DOI · Paper page
  58. Heyvaert, 2014, Randomization and data-analysis items in quality standards for single-case experimental studies, J Spec Educ
  59. Shadish, 2014, Statistical analyses of single-case designs the shape of things to come, Curr Direct Psychol Sci, 23, 139, 10.1177/0963721414524773 · DOI · Paper page
  60. Bailar, 1988, Guidelines for statistical reporting in articles for medical journals. amplifications and explanations, Ann Intern Med, 108, 266, 10.7326/0003-4819-108-2-266 · DOI · Paper page
  61. Zucker, 2006, Lessons learned combining N-of-1 trials to assess fibromyalgia therapies, J Rheumatol, 33, 2069
  62. Maggin, 2011, A quantitative synthesis of methodology in the meta-analysis of single-subject research for students with disabilities: 1985–2009, Exceptionality, 19, 109, 10.1080/09362835.2011.565725 · DOI · Paper page
  63. Gage, 2012, Hierarchical linear modeling meta-analysis of single-subject design research, J Spec Educ
  64. Moher, 2009, Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement, Ann Intern Med, 151, 264, 10.7326/0003-4819-151-4-200908180-00135 · DOI · Paper page
  65. Haas, 2004, Dextroamphetamine pilot crossover trials and n of 1 trials in patients with chronic tension-type and migraine headache, Headache, 44, 1029, 10.1111/j.1526-4610.2004.04199.x · DOI
  66. Maggin, 2011, A generalized least squares regression approach for computing effect sizes in single-case research: application examples, J Sch Psychol, 49, 301, 10.1016/j.jsp.2011.03.004 · DOI
  67. Rochon, 1990, A statistical model for the “N-of-1” study, J Clin Epidemiol, 43, 499, 10.1016/0895-4356(90)90139-G · DOI
  68. Parker, 2007, Percentage of all non-overlapping data (PAND) an alternative to PND, J Spec Educ, 40, 194, 10.1177/00224669070400040101 · DOI · Paper page
  69. Johnston, 2010, Single subject designs: current methodologies and future directions, OTJR, 30, 4
  70. Gordon, 1996, Valproic acid treatment of learning disorder and severely epileptiform EEG without clinical seizures, J Child Neurol, 11, 41, 10.1177/088307389601100110 · DOI
  71. Dales, 1992, Chronic cough responsive to ibuprofen, Pharmacotherapy, 12, 331, 10.1002/j.1875-9114.1992.tb04467.x · doi:10.1002/j.1875-9114.1992.tb04467.x
  72. Estrada, 1993, Patient preferences for novel therapy: an N-of-1 trial of garlic in the treatment for hypertension, J Gen Intern Med, 8, 619, 10.1007/BF02599719 · doi:10.1007/bf02599719
  73. Lehman, 2012, Missing clinical trial data, BMJ, 344, 10.1136/bmj.d8158 · DOI
  74. Avins, 2005, Use of an embedded N-of-1 trial to improve adherence and increase information from a clinical study, Contemp Clin Trials, 26, 397, 10.1016/j.cct.2005.02.004 · doi:10.1016/j.cct.2005.02.004
  75. Reed, 2005, AB/BA crossover trials-binary outcome, J Mod App Stat Meth, 5, 19, 10.22237/jmasm/1162354680 · doi:10.22237/jmasm/1162354680
  76. Johannessen, 1991, The symptomatic effect of 1-day treatment periods with cimetidine in dyspepsia. combined results from randomized, controlled, single-subject trials, Scand J Gastroenterol, 26, 974, 10.3109/00365529108996251 · DOI
  77. Yelland, 2007, Celecoxib compared with sustained-release paracetamol for osteoarthritis: a series of n-of-1 trials, Rheumatology (Oxford), 46, 135, 10.1093/rheumatology/kel195 · DOI · Paper page
  78. Van, 1995, N of 1 study: amantadine for the amotivational syndrome in a patient with traumatic brain injury, Brain Inj, 9, 49, 10.3109/02699059509004571 · DOI · Paper page
  79. Nikles, 2006, An n-of-1 trial service in clinical practice: testing the effectiveness of stimulants for attention-deficit/hyperactivity disorder, Pediatrics, 117, 2040, 10.1542/peds.2005-1328 · DOI · Paper page
  80. Tison, 2013, Simvastatin decreases levodopa-induced dyskinesia in monkeys, but not in a randomized, placebo-controlled, multiple cross-over (“n-of-1”) exploratory trial of simvastatin against levodopa-induced dyskinesia in parkinson’s disease patients, Parkinsonism Relat Disord, 19, 416, 10.1016/j.parkreldis.2012.12.003 · DOI
  81. Paz-Filho, 2008, Leptin replacement improves cognitive development, PLoS One, 3, e3098, 10.1371/journal.pone.0003098 · DOI · Paper page
  82. Chalmers, 2009, Avoidable waste in the production and reporting of research evidence, Obstet Gynecol, 114, 1341, 10.1097/AOG.0b013e3181c3020d · DOI · Paper page

Cited by

See all 143

Metadata

Authors
Shamseer, L., Sampson, M., Bukutu, C., Schmid, C. H., Nikles, J., Tate, R., Johnston, B. C., Zucker, D., Shadish, W. R., Kravitz, R., Guyatt, G., Altman, D. G., Moher, D., Vohra, S., Altman, D. G., Bukutu, C., Clark, J., Cogo, E., Gabler, N. B., Guyatt, G., Kravitz, R., Janosky, J., Johnston, B. C., Li, B., Mahon, J., Marles, R., Moher, D., Nikles, J., Sampson, M., Schmid, C. H., Shadish, W. R., Shamseer, L., Tate, R., Vohra, S., & Zucker, D.
Venue
Journal of Clinical Epidemiology
Publisher
Elsevier BV
Published
2016-08
Volume
76
Pages
18-46
ISSN
0895-4356 (ISSN-L)
OpenAlex
W1524110242
Cited by
143
References
25
FWCI
12.56
Type
journal article
Language
en
Open access
hybrid
Licence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.